PMC:7289100 / 42033-42226
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T318 | 3-4 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T179 | 71-82 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T257 | 0-193 | Sentence | denotes | In a report from China by Xu et al. the authors were able to show that tocilizumab effectively improved clinical symptoms as well as reversed the deterioration of sever Covid-19 patients [117]. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T574 | 71-82 | DG_35 | denotes | tocilizumab |
| T575 | 169-177 | SP_7 | denotes | Covid-19 |
| T60533 | 71-82 | DG_35 | denotes | tocilizumab |
| T64207 | 169-177 | SP_7 | denotes | Covid-19 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1417 | 178-186 | Species | denotes | patients | Tax:9606 |
| 1421 | 71-82 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 1433 | 169-177 | Disease | denotes | Covid-19 | MESH:C000657245 |